FDA applicant
Curetis GmbH
FDA records 2 decisions for Curetis GmbH (Holzgerlingen, DE) from 2018 to 2019: 1 510(k) clearance and 1 De Novo grant. All are in product code QBH (Lower Respiratory Microbial Nucleic Acid…). Its devices cite 1 predicate, 1 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Curetis GmbH’s devices, and how often a recall has named them.
FDA decisions per year
1in 2019
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2018.
Planning a device like Curetis GmbH’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report